Normal function · from ai-gene-review (P10275, commit 79fe13b38970) · AI-generated, not KB evidence

The androgen receptor (AR; NR3C4) is an intracellular steroid receptor with an N-terminal transcriptional activation domain containing a polymorphic polyglutamine tract, a zinc-finger DNA-binding domain and a C-terminal ligand-binding domain. Full-length AR recognizes androgens, moves between cytosolic and nuclear pools, binds regulatory DNA and recruits context-dependent coactivators or corepressors to control transcription. It supports male sexual differentiation, reproductive function and tissue-specific androgen responses. Alternative products, including AR-V7, can alter ligand dependence and transcriptional behavior. The disordered activation domain supports molecular condensation as one mode of receptor assembly. Loss-of-function variants cause androgen insensitivity, whereas expansion of the CAG-encoded polyglutamine tract causes spinal and bulbar muscular atrophy. Dysregulated AR signaling, including altered abundance, ligand responses and splice products, contributes to prostate cancer progression.

Full-length AR recognizes and binds androgen through its ligand-binding domain, then combines regulatory-DNA recognition with coregulator recruitment to activate or repress Pol II transcription. This ligand-sensing transcriptional activity supports androgen receptor signaling. Ligand-binding-domain-deficient products can retain distinct constitutive transcriptional behavior. Nuclear/chromatin pools perform DNA-directed transcription; cytosol is a regulated receptor pool preceding or following nuclear entry.
Condensation is a mode of AR assembly associated with transcriptional regulation. Purified human activation-domain fragments establish intrinsic condensate formation under defined solution conditions, while a separate receptor study reports ligand-activated transcriptional condensates. These results do not establish that every nuclear focus is liquid or that every splice product has identical phase behavior.
molecular function: molecular condensate scaffold activity · directly involved in: membraneless organelle assembly
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Androgen Insensitivity Syndrome causative
mechanism: Pathogenic AR Variation
subtype: CAIS; MAIS; PAIS
animal model: Sertoli-cell androgen receptor knockout mouse; Ubiquitous androgen receptor knockout mouse
Androgenetic Alopecia susceptibility germline
mechanism: Dihydrotestosterone-Androgen Receptor Signaling; Polygenic Susceptibility; Regional Androgen Receptor Abundance
Vulvodynia susceptibility
mechanism: Androgen Receptor Signalling Insufficiency
Benign Prostatic Hyperplasia untyped
Risk Factor
Kennedy Disease untyped
Causative
treatment: Antisense oligonucleotide AR-lowering therapy (experimental)
diagnosis: Molecular genetic testing
Klinefelter Syndrome untyped
Androgen signaling pathway
Polycystic Ovary Syndrome untyped
Risk Factor
Prostate Adenocarcinoma untyped
Amplification, activating mutation, or splice variant expression during progression
BRCA-Mutant Prostate Cancer no genetic record
mechanism: PARP-Androgen Receptor Co-Dependency
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
Kennedy disease MONDO:0010735 XL Definitive
2023-08-08

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.